PHI with Cystic kidney
How does this condition affect your private health insurance?
Autosomal Dominant Polycystic Kidney Disease (ADPKD), often referred to as "Zystenniere", is a genetic disorder characterized by the growth of numerous fluid-filled cysts in the kidneys. These cysts gradually enlarge, compromising kidney function and leading to kidney failure in approximately 50% of affected individuals by age 60. Cysts can also develop in other organs like the liver. Symptoms include pain, hematuria, hypertension, and recurrent UTIs. Progressive kidney damage often necessitates dialysis or kidney transplantation, making early management crucial for slowing disease progression and treating complications.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Variable, often insidious with initial symptoms (e.g., pain, hypertension) appearing in adulthood over weeks to months.
Duration of Illness (Lifetime)
Chronic and progressive throughout a lifetime, typically leading to end-stage renal disease over several decades.
Cost of Treatment (Initial)
Moderate (diagnosis, imaging, initial medication for hypertension or pain management).
Cost of Treatment (Lifetime)
High to very high (long-term medication, frequent monitoring, potential dialysis, kidney transplant, and management of systemic complications).
Mortality Rate
Moderate to high over a lifetime due to complications such as kidney failure, cardiovascular events, or ruptured cerebral aneurysms, especially if not well-managed.
Risk of Secondary Damages
High (hypertension, chronic kidney disease progressing to end-stage renal disease, liver cysts, cerebral aneurysms, cardiac valvular disease, diverticulosis).
Probability of Full Recovery
Very low; there is currently no cure, only management of symptoms and progression.
Underlying Disease Risk
High probability of co-occurring conditions such as hypertension, urinary tract infections, kidney stones, liver cysts, and cerebral aneurysms.